2026-05-17T00:20:34Zhttps://repisalud.isciii.es/rest/oai/request

oai:repisalud.isciii.es:20.500.12105/270072025-12-18T12:57:31Zcom_20.500.12105_19586com_20.500.12105_2202col_20.500.12105_19587

00925njm 22002777a 4500 dc Cañas-Alvaro, Rodrigo author Lalaguna, Laura author Rubio, Blanca author Ausiello, Antonella author López-Olañeta, Marina author Serrano-Blanco, Rocío F author Ochoa, Juan Pablo author de la Pompa, Jose Luis author Chavez, Alejandro author García-Pavía, Pablo author Lara-Pezzi, Enrique author 2025-11-14 Eur Heart J. 2025 Nov 14;46(43):4610-4613. https://doi.org/10.1093/eurheartj/ehaf703 40886060 https://hdl.handle.net/20.500.12105/27007 CRISPR activation Cardiomyopathy Dilated cardiomyopathy FLNC truncating variants Gene therapy Non-dilated left ventricular cardiomyopathy CRISPR activation to repair electrocardiogram abnormalities caused by a FLNC truncating variant in mice.